Clayton, Dubilier & Rice Completes Acquisition of Healogics from Metalmark Capital

NEW YORK - July 1, 2014 - Clayton, Dubilier & Rice (“CD&R”) and Healogics Holding Corp. (“Healogics”) announced today that funds managed by CD&R have completed the previously-announced acquisition of Healogics, the largest advanced wound care services provider in the United States, from Metalmark Capital and Scale Venture Partners. The transaction is valued at approximately $910 million. Additional terms were not disclosed.

“CD&R is a proven builder of businesses and we are pleased to welcome the firm as our new partner,” said Healogics President and CEO Jeff Nelson. “We thank the Metalmark team for its help in making us a premier provider of wound care services with the scale and services required to meet the critical needs of patients suffering from debilitating and chronic wounds across the healthcare continuum. We look forward to this next chapter in our history.”

With approximately $300 million in sales and more than 2,000 employees, Healogics operates nearly 600 hospital outpatient Wound Care Centers®, or roughly one-third of all hospital outpatient wound care centers in the United States, and treated over 215,000 patients in 2013. In addition, the company operates Sechrist Industries, the leading global manufacturer of hyperbaric oxygen therapy chambers ("HBOTCs") used in advanced wound care. Inc. magazine recently named Healogics, Inc. on its exclusive ranking of the nation's fastest-growing private companies. Healogics also was recognized on Modern Healthcare's list of 'Healthcare's Hottest' companies for 2013.


Clayton, Dubilier & Rice Completes Acquisition of Healogics from Metalmark Capital

NEW YORK - July 1, 2014 - Clayton, Dubilier & Rice (“CD&R”) and Healogics Holding Corp. (“Healogics”) announced today that funds managed by CD&R have completed the previously-announced acquisition of Healogics, the largest advanced wound care services provider in the United States, from Metalmark Capital and Scale Venture Partners. The transaction is valued at approximately $910 million. Additional terms were not disclosed.

“CD&R is a proven builder of businesses and we are pleased to welcome the firm as our new partner,” said Healogics President and CEO Jeff Nelson. “We thank the Metalmark team for its help in making us a premier provider of wound care services with the scale and services required to meet the critical needs of patients suffering from debilitating and chronic wounds across the healthcare continuum. We look forward to this next chapter in our history.”

With approximately $300 million in sales and more than 2,000 employees, Healogics operates nearly 600 hospital outpatient Wound Care Centers®, or roughly one-third of all hospital outpatient wound care centers in the United States, and treated over 215,000 patients in 2013. In addition, the company operates Sechrist Industries, the leading global manufacturer of hyperbaric oxygen therapy chambers ("HBOTCs") used in advanced wound care. Inc. magazine recently named Healogics, Inc. on its exclusive ranking of the nation's fastest-growing private companies. Healogics also was recognized on Modern Healthcare's list of 'Healthcare's Hottest' companies for 2013.